Jacob Cox, MD
Retina Specialist · Knoxville, TNNPI 1811387061
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (33.0%), consulting fees and grants — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 35.4% of the total. Reporting peaked in 2024 at $2,327 and has fallen 66.5% since, to $779 in 2025.
Across 46 payments — averaging $137.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$2K
- Regeneron$1K
- AbbVie$1K
- Alimera Sciences, Inc.$460
- Apellis Pharmaceuticals, Inc.$399
- Alcon$285
- plus $473 from 7 others
What the payments were for
- Consulting fees$1,67526%
- Speaking & faculty fees$4607%
- Grants$1,30020%
- Travel & lodging$81913%
- Food & beverage$2,09333%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 20 | $2,249 |
| Regeneron | 3 | $1,359 |
| AbbVie | 3 | $1,122 |
| Alimera Sciences, Inc. | 1 | $460 |
| Apellis Pharmaceuticals, Inc. | 4 | $399 |
| Alcon | 4 | $285 |
| Genentech, Inc. | 2 | $153 |
| Astellas Pharma Global Development | 1 | $92 |
| Regeneron Healthcare Solutions, Inc. | 2 | $73 |
| Genentech USA, Inc. | 2 | $57 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $38 |
| Astellas Pharma US Inc | 1 | $35 |
| Eyepoint US, Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OZURDEX$1,050
- STELLARIS$997
- OPHTHALMIC INSTRUMENTS$997
- STELLARIS ELITE$625
- Iluvien$460
- YUTIQ$460
- Syfovre$234
- Constellation$110
How this compares
$6,347 in reported general payments places this provider in the 70th percentile of 58 retina specialist providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 87 | $3,106 |
| Difluprednate | 13 | $1,181 |
| Atropine Sulfate | 33 | $1,168 |
| Ketorolac Tromethamine | 13 | $445 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 31 | $430 |
| Ciprofloxacin Hcl | 29 | $347 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 27 | $341 |
| Latanoprost | 35 | $330 |
| Brimonidine Tartrate | 14 | $249 |
| Timolol Maleate | 17 | $170 |
| Gentamicin Sulfate | 11 | $99 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Knoxville
- Nicholas AndersonKnoxville$46K
- Timothy StoutKnoxville$13K
- Jonathan FuerstKnoxville$3K
- Robert ShulerKnoxville$3K
- James MillerKnoxville$3K
- Joseph GoogeKnoxville$2K
- Stephen PerkinsKnoxville$2K
- Ailee LahamKnoxville$2K
- Tod McMillanKnoxville$850
- Steve CharlesGermantown$5.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.